Showing results (31-40 of 216) with videos related to
Sort By:
Pageof 22
HIV Clinical Trials|November 9, 2012
Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra studyL Schneider, N Ktorza, S Fourati, et al.Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 1, 1994
[Parvovirus B19 and pediatric pathology]G Tchernia, E Dussaix, Y LaurianThe Journal of Antimicrobial Chemotherapy|May 28, 2016
Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combinationS Lambert-Niclot, C Allavena, M Grude, et al.Infection|October 25, 2013
Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity scoreF Caby, L Schneider, C Blanc, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 31, 2016
Performance of genotypic algorithms for predicting tropism of HIV-1CRF02_AG subtypeC Soulié, D B Fofana, N Boukli, et al.HIV Medicine|April 27, 2017
Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populationsE Todesco, C Charpentier, M Bertine, et al.The Journal of Antimicrobial Chemotherapy|December 5, 2013
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapyS Lambert-Niclot, C Charpentier, A Storto, et al.Journal of Medical Virology|March 25, 2008
National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutationC Delaugerre, P Flandre, A G Marcelin, et al.Archives Francaises De Pediatrie|February 1, 1986
[Neuropathy of the brachial plexus complicating infectious mononucleosis in an 18-month-old child]E Dussaix, P Le Touzé, M TardieuThe Journal of Antimicrobial Chemotherapy|May 29, 2016
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patientsL Bocket, G Peytavin, E K Alidjinou, et al.Pageof 22